Enodia Therapeutics
PrivateLast Round
Seed
Jan 8, 2026
Total Funding Raised
$25M
Momentum Score
50 /100
Company Overview
Enodia Therapeutics is a biotechnology company that develops small-molecule therapies that enable the degradation of disease-driving proteins at the point of synthesis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enodia Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Enodia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 8, 2026 |
Enodia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investsud | Seed |
| Elaia Partners | Seed |
| Wallonie Entreprendre | Seed |
| Bpifrance | Seed |
| Pfizer Ventures | Seed |
| Mission BioCapital | Seed |
| Institut Pasteur | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Grew 300% QoQ, from 2 to 8 employees.
- Apr 15, 2026
Dr. Yvonne McGrath appointed to lead scientific strategy.
Enodia Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Enodia Therapeutics's valuation, stock price, and market status.
